目的观察葛根地榆紫草汤组方治疗活动期溃疡性结肠炎(UC)的临床疗效及对炎症因子的影响。方法选取2017年6月至2018年12月收治的120例活动期UC患者,按随机数字表法分为观察组和对照组,各60例。2组患者均给予活动期UC常规治疗,对照组患者...目的观察葛根地榆紫草汤组方治疗活动期溃疡性结肠炎(UC)的临床疗效及对炎症因子的影响。方法选取2017年6月至2018年12月收治的120例活动期UC患者,按随机数字表法分为观察组和对照组,各60例。2组患者均给予活动期UC常规治疗,对照组患者加用美沙拉嗪缓释片1 g,3次/d进行治疗;观察组给予葛根地榆紫草汤125 ml 2次/d联合美沙拉嗪缓释片1 g,3次/d进行治疗,疗程均为6周。观察2组患者治疗前后血清炎症因子水平,比较2组患者的Baron结肠内镜评分、临床症状评分、治疗有效率、复发率及不良反应发生率。结果治疗后,观察组白细胞介素-1、白细胞介素-6、环加氧酶-2、肿瘤坏死因子-α水平均明显低于对照组,而白细胞介素-10明显高于对照组,差异均具有统计学意义(P<0.05);观察组Baron内镜评分明显低于对照组(P<0.05);2组治疗后临床症状均明显好转,观察组治疗后临床症状评分明显低于对照组(P<0.05);观察组总有效率明显优于对照组(P<0.05),且不良反应发生率差异无统计学意义(P>0.05);治疗后随访2个月,观察组复发率明显低于对照组(P<0.05)。结论葛根地榆紫草汤组方治疗UC患者的临床效果较好,能够有效减轻机体炎症反应,明显改善UC患者的临床症状,复发率低,安全性高,值得临床应用。展开更多
Background: The etiology of Crohn’s disease (CD) and Ulcerative Colitis (UC) remains unclear. It has been suggested that apart from genetic factors, prenatal or perinatal environmental factors could change the risk o...Background: The etiology of Crohn’s disease (CD) and Ulcerative Colitis (UC) remains unclear. It has been suggested that apart from genetic factors, prenatal or perinatal environmental factors could change the risk of developing inflammatory bowel disease (IBD) later in life. Seasonality in birth distribution over the year has been demonstrated for several immune diseases, but studies on IBD have had inconsistent results. Aim: The aim of this study was to investigate in the Netherlands the effect of the month of birth on the probability to develop IBD later in life. Methods: Birth data from CD patients and UC patients of 4 different Dutch hospitals were compared to a control group of irritable bowel syndrome (IBS) patients from the same hospitals. A chi-square test was used to test whether there was heterogeneity between the monthly and seasonal birth rates of the three groups. Results: The patient cohort consisted of 1183 CD patients and 1293 UC patients. The control group consisted of 2113 IBS patients. Data showed no difference in birth distribution over the year or over the four seasons of IBD patients as compared to the control group. P-values over the year and over the seasons respectively are 0.428 and 0.237 for CD and 0.311 and 0.812 for UC. Conclusions: There is no seasonality in the distribution of births of IBD patients as compared to controls. The hypothesis that environmental factors present at the time of birth play a role in the pathogenesis of IBD is not supported by these data.展开更多
文摘目的观察葛根地榆紫草汤组方治疗活动期溃疡性结肠炎(UC)的临床疗效及对炎症因子的影响。方法选取2017年6月至2018年12月收治的120例活动期UC患者,按随机数字表法分为观察组和对照组,各60例。2组患者均给予活动期UC常规治疗,对照组患者加用美沙拉嗪缓释片1 g,3次/d进行治疗;观察组给予葛根地榆紫草汤125 ml 2次/d联合美沙拉嗪缓释片1 g,3次/d进行治疗,疗程均为6周。观察2组患者治疗前后血清炎症因子水平,比较2组患者的Baron结肠内镜评分、临床症状评分、治疗有效率、复发率及不良反应发生率。结果治疗后,观察组白细胞介素-1、白细胞介素-6、环加氧酶-2、肿瘤坏死因子-α水平均明显低于对照组,而白细胞介素-10明显高于对照组,差异均具有统计学意义(P<0.05);观察组Baron内镜评分明显低于对照组(P<0.05);2组治疗后临床症状均明显好转,观察组治疗后临床症状评分明显低于对照组(P<0.05);观察组总有效率明显优于对照组(P<0.05),且不良反应发生率差异无统计学意义(P>0.05);治疗后随访2个月,观察组复发率明显低于对照组(P<0.05)。结论葛根地榆紫草汤组方治疗UC患者的临床效果较好,能够有效减轻机体炎症反应,明显改善UC患者的临床症状,复发率低,安全性高,值得临床应用。
文摘Background: The etiology of Crohn’s disease (CD) and Ulcerative Colitis (UC) remains unclear. It has been suggested that apart from genetic factors, prenatal or perinatal environmental factors could change the risk of developing inflammatory bowel disease (IBD) later in life. Seasonality in birth distribution over the year has been demonstrated for several immune diseases, but studies on IBD have had inconsistent results. Aim: The aim of this study was to investigate in the Netherlands the effect of the month of birth on the probability to develop IBD later in life. Methods: Birth data from CD patients and UC patients of 4 different Dutch hospitals were compared to a control group of irritable bowel syndrome (IBS) patients from the same hospitals. A chi-square test was used to test whether there was heterogeneity between the monthly and seasonal birth rates of the three groups. Results: The patient cohort consisted of 1183 CD patients and 1293 UC patients. The control group consisted of 2113 IBS patients. Data showed no difference in birth distribution over the year or over the four seasons of IBD patients as compared to the control group. P-values over the year and over the seasons respectively are 0.428 and 0.237 for CD and 0.311 and 0.812 for UC. Conclusions: There is no seasonality in the distribution of births of IBD patients as compared to controls. The hypothesis that environmental factors present at the time of birth play a role in the pathogenesis of IBD is not supported by these data.
